Nanjing Ange Pharmaceutical Co., Ltd. was founded in 2003, and is now a leading company in the Chinese pharmaceutical industry, specializing in the development of 鈥淣ew Drugs鈥?(the drugs that previously have not been marketed in China, i.e., New Chemical Entities) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.
We hire a staff of thirty-five people, among whom three hold PhD. degrees and five master degrees. In addition, our associates include eight experts from renowned Chinese institutes such as China Pharmaceutical University. With almost every major university in Nanjing we have established cooperative relationships and laboratories.
Our main products are Antineoplastic medicines (Sunitinib, Lapatinib, Nilotinib, Dasatinib, Gefitinib, Erlotinib, Imatinib, canertinib) and relative pharmaceutical intermediates, etc. We boast facilities such as a R&D centre equipped with leading instruments like Waters HPLC.
Recently, we have been working with Abbott Laboratories Ltd. and Simcere Pharmaceutical Group, etc.
Holding up the philosophy that 鈥淨uality Technology and Service Foster Healthy Life,鈥? Ange looks forward to establishing long-term, steady cooperative relationships with customers from around the globe.